ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Tumour flare,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
2,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
5,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,2,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
9,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10,1,Autoimmune myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
10,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
10,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
11,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
12,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
13,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
13,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
14,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
16,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
16,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
17,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
18,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
19,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
20,2,Plague,Yersinia infections,Bacterial infectious disorders,Infec,N
21,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
22,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
